Cargando…
Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation
Pelizaeus-Merzbacher disease (PMD) is a central nervous system (CNS) demyelinating disease in human, currently known as prototypic hypomyelinating leukodystrophy 1 (HLD1). The gene responsible for HLD1 encodes proteolipid protein 1 (PLP1), which is the major myelin protein produced by oligodendrocyt...
Autores principales: | Matsumoto, Naoto, Watanabe, Natsumi, Iibe, Noriko, Tatsumi, Yuriko, Hattori, Kohei, Takeuchi, Yu, Oizumi, Hiroaki, Ohbuchi, Katsuya, Torii, Tomohiro, Miyamoto, Yuki, Yamauchi, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849085/ https://www.ncbi.nlm.nih.gov/pubmed/31737794 http://dx.doi.org/10.1016/j.bbrep.2019.100705 |
Ejemplares similares
-
Hypomyelinating Leukodystrophy 7 (HLD7)-Associated Mutation of POLR3A Is Related to Defective Oligodendroglial Cell Differentiation, Which Is Ameliorated by Ibuprofen
por: Sawaguchi, Sui, et al.
Publicado: (2021) -
Hypomyelinating Leukodystrophy 8 (HLD8)-Associated Mutation of POLR3B Leads to Defective Oligodendroglial Morphological Differentiation Whose Effect Is Reversed by Ibuprofen
por: Sawaguchi, Sui, et al.
Publicado: (2022) -
Hypomyelinating Leukodystrophy 15 (HLD15)-Associated Mutation of EPRS1 Leads to Its Polymeric Aggregation in Rab7-Positive Vesicle Structures, Inhibiting Oligodendroglial Cell Morphological Differentiation
por: Sawaguchi, Sui, et al.
Publicado: (2021) -
Molecular Pathogenic Mechanisms of Hypomyelinating Leukodystrophies (HLDs)
por: Torii, Tomohiro, et al.
Publicado: (2023) -
RARS1‐related hypomyelinating leukodystrophy: Expanding the spectrum
por: Mendes, Marisa I., et al.
Publicado: (2019)